Articles From: Acacia Research to Present at the Citi 2014 Global Technology Conference to Acadia Realty Trust Reports Second Quarter 2014 Operating Results


Acacia Research Corporation (NASDAQ: ACTG) announced today that its CEO and President, Matthew Vella, will discuss Acacia's patent licensing business at the Citi 2014 Global Technology Conference.
Sign-up for Acacia Research to Present at the Citi 2014 Global Technology Conference investment picks
Acacia Research Corporation (NASDAQ: ACTG) announced today it will release its second quarter financial results on Thursday, July 24, 2014.
Sign-up for Acacia Research to Release Second Quarter Financial Results and Host Conference Call investment picks
Acacia Research Corporation (NASDAQ: ACTG) announced today that its Innovative Display Technologies LLC and Delaware Display Group LLC subsidiaries has entered into an agreement with RPX Corporation.
Sign-up for Acacia Subsidiaries Enter into an Agreement with RPX Corporation investment picks
Acacia Research Corporation (NASDAQ: ACTG) announced today that its O.S. Security LLC subsidiary has entered into a settlement agreement with Kaba Ilco Corporation and Kaba Holding AG.
Sign-up for Acacia Subsidiary Enters into a Settlement Agreement with Kaba Ilco Corporation and Kaba Holding AG investment picks
2014/8/20
Acacia Research Corporation announced today that its ADAPTIX, Inc. subsidiary has entered into an agreement granting a limited term patent license to Sharp Corporation.
Sign-up for Acacia Subsidiary Enters into Agreement with Sharp Corporation investment picks
Acacia Research Corporation (NASDAQ: ACTG) announced today that its Saint Lawrence Communications LLC subsidiary has entered into a royalty-bearing patent license agreement with Dialogic Inc. ABOUT ACACIA RESEARCH CORPORATION Founded in 1993, Acacia Research Corporation (NASDAQ: ACTG) is the industry leader in patent licensing.
Sign-up for Acacia Subsidiary Enters Into Royalty-Bearing Patent License Agreement With Dialogic Inc. investment picks
Acacia Research Corporation (NASDAQ: ACTG) announced today that its Saint Lawrence Communications LLC subsidiary has entered into a royalty-bearing patent license agreement with Tecnotree OYJ.
Sign-up for Acacia Subsidiary Enters into Royalty-Bearing Patent License Agreement with Tecnotree OYJ investment picks
Acacia Research Corporation (NASDAQ: ACTG) announced today that its Promethean Insulation Technology LLC subsidiary has entered into a settlement agreement resolving all disputes with Pregis Corporation, Pregis Innovative Packaging Corporation, Innovative Energy, Inc. and Energie Innovation, Inc. ABOUT ACACIA RESEARCH CORPORATION Founded in 1993, Acacia Research Corporation (NASDAQ: ACTG) is the industry leader in patent licensing.
Sign-up for Acacia Subsidiary Enters into Settlement & Patent License Agreement with Pregis Corporation, Pregis Innovative Packaging Corporation, Innovative Energy, Inc. & Energie Innovation, Inc. investment picks
Acacia Research Corporation (NASDAQ: ACTG) announced today that its O.S. Security LLC subsidiary has entered into a settlement and patent license agreement with Alarm Lock Systems, Inc. The agreement resolves litigation that was pending in the United States District Court for the Central District of California.
Sign-up for Acacia Subsidiary Enters into Settlement and Patent License Agreement with Alarm Lock Systems, Inc. investment picks
Acacia Research Corporation (NASDAQ:ACTG) announced today that its Bonutti Skeletal Innovations LLC subsidiary has entered into a settlement and patent license agreement with Arthrex, Inc. The agreement resolves litigation that was pending in the United States District Court for the Middle District of Florida.
Sign-up for Acacia Subsidiary Enters into Settlement and Patent License Agreement with Arthrex, Inc. investment picks
Acacia Research Corporation (NASDAQ: ACTG) announced today that its Auto-Dimensions LLC subsidiary has entered into a settlement and patent license agreement with Autodesk, Inc. The agreement resolves litigation that was pending in the United States District Court for the Eastern District of Texas.
Sign-up for Acacia Subsidiary Enters into Settlement and Patent License Agreement with Autodesk, Inc. investment picks
Acacia Research Corporation (NASDAQ: ACTG) announced today that its Brandywine Communications Technologies LLC subsidiary has entered into a settlement and patent license agreement with Consolidated Communications Holdings, Inc. The agreement resolves litigation that was pending in the United States District Court for the District of Delaware.
Sign-up for Acacia Subsidiary Enters into Settlement and Patent License Agreement with Consolidated Communications Holdings, Inc. investment picks
Acacia Research Corporation (NASDAQ: ACTG) announced today that its Labyrinth Optical Technologies LLC subsidiary has entered into a settlement and patent license agreement with Fujitsu Network Communications, Inc. The agreement resolves litigation that was pending in the United States District Court for the Central District of California.
Sign-up for Acacia Subsidiary Enters into Settlement and Patent License Agreement with Fujitsu Network Communications, Inc. investment picks
Acacia Research Corporation (NASDAQ: ACTG) announced today that its Progressive Semiconductor Solutions LLC subsidiary has entered into a settlement and patent license agreement with Marvell International Limited.
Sign-up for Acacia Subsidiary Enters into Settlement and Patent License Agreement with Marvell International Limited investment picks
Acacia Research Corporation (NASDAQ: ACTG) announced today that its Innovative Display Technologies LLC subsidiary has entered into a settlement and patent license agreement with MiTAC Digital Corporation d/b/a Magellan and MiTAC International Corporation.
Sign-up for Acacia Subsidiary Enters into Settlement and Patent License Agreement with MiTAC Digital Corporation d/b/a Magellan and MiTAC International Corporation investment picks
Acacia Research Corporation (NASDAQ: ACTG) announced today that its Super Resolution Technologies LLC subsidiary has entered into a settlement and patent license agreement with Nikon Corporation and Nikon Instruments Inc. The agreement resolves litigation that was pending in the United States District Court for the Northern District of Texas.
Sign-up for Acacia Subsidiary Enters Into Settlement and Patent License Agreement With Nikon Corporation and Nikon Instruments Inc. investment picks
2014/9/10
Praise for Shiva Rea: SILVER SPRING, Md., Sept.
Sign-up for Acacia TV is the Premier Destination to Stream Shiva Rea's Award-Winning Workouts investment picks
BURLINGTON, Mass., Sept.
Sign-up for Academy of Interactive and Visual Arts Honors Bridgeline With Three W3 Awards investment picks
2014/8/19
ADVISORY, Aug.
Sign-up for Academy of Nutrition and Dietetics to Ring The NASDAQ Stock Market Closing Bell investment picks
Acadia Healthcare Company, Inc. (“Acadia” or the “Company”) (NASDAQ: ACHC) today announced that it will release its second quarter 2014 earnings on Tuesday, July 29, 2014, after the market closes.
Sign-up for Acadia Healthcare Announces Date for Second Quarter 2014 Earnings Release investment picks
Acadia Healthcare Company, Inc. (NASDAQ: ACHC) today announced financial results for the second quarter and six months ended June 30, 2014.
Sign-up for Acadia Healthcare Reports Second Quarter Adjusted EPS Increase of 23.1% to $0.32 on 20.5% Growth in Revenue investment picks
Acadia Healthcare Company, Inc. (NASDAQ: ACHC) today announced that the Company will participate in the Robert W.
Sign-up for Acadia Healthcare to Present at Robert W. Baird & Co. 2014 Health Care Conference investment picks
ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD), a biopharmaceutical company focused on the development and commercialization of innovative medicines that address unmet medical needs in neurological and related central nervous system disorders, announced the appointment of Stephen Davis as Executive Vice President, Chief Financial Officer and Chief Business Officer, effective today.
Sign-up for ACADIA Pharmaceuticals Announces Appointment of Stephen Davis as Executive Vice President, Chief Financial Officer and Chief Business Officer investment picks
ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD), a biopharmaceutical company focused on the development and commercialization of innovative medicines to address unmet medical needs in neurological and related central nervous disorders, today announced that the U.S. Food and Drug Administration (FDA) has provisionally accepted the trade name “NUPLAZID”™ for pimavanserin.
Sign-up for ACADIA Pharmaceuticals Announces Trade Name NUPLAZID™ for Pimavanserin investment picks
ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD), a biopharmaceutical company focused on the development and commercialization of innovative medicines to address unmet medical needs in neurological and related central nervous system disorders, today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to NUPLAZID™ (pimavanserin) for the treatment of Parkinson’s disease psychosis.
Sign-up for ACADIA Pharmaceuticals Receives FDA Breakthrough Therapy Designation for NUPLAZID™ (Pimavanserin) for Parkinson’s Disease Psychosis investment picks
ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD), a biopharmaceutical company focused on the development and commercialization of innovative medicines that address unmet medical needs in neurological and related central nervous system disorders, today announced its unaudited financial results for the second quarter ended June 30, 2014.
Sign-up for ACADIA Pharmaceuticals Reports Second Quarter 2014 Financial Results investment picks
ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD), a biopharmaceutical company focused on the development and commercialization of innovative medicines that address unmet medical needs in neurological and related central nervous system disorders, today announced that it will report its unaudited financial results for the second quarter ended June 30, 2014 on Tuesday, August 5, 2014, after the U.S. financial markets close.
Sign-up for ACADIA Pharmaceuticals to Announce Second Quarter 2014 Financial Results on August 5, 2014 investment picks
Acadia Realty Trust (NYSE:AKR), today announced the Company’s dividend for the quarter ending September 30, 2014.
Sign-up for Acadia Realty Trust Announces Quarterly Dividend investment picks
Acadia Realty Trust (NYSE:AKR) today announced that it has completed both the previously-reported sale of six retail properties in Miami Beach, Florida owned by its fund platform and the acquisition of a retail property in Manhattan’s Soho submarket on behalf of its core portfolio.
Sign-up for Acadia Realty Trust Provides Update on $392 Million of Transactions investment picks
Acadia Realty Trust (NYSE:AKR) today reported operating results for the quarter ended June 30, 2014.
Sign-up for Acadia Realty Trust Reports Second Quarter 2014 Operating Results investment picks
Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Articles From: Acacia Research to Present at the Citi 2014 Global Technology Conference to Acadia Realty Trust Reports Second Quarter 2014 Operating Results
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices